ARDIZZOIA, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 540
EU - Europa 221
AS - Asia 57
OC - Oceania 1
SA - Sud America 1
Totale 820
Nazione #
US - Stati Uniti d'America 537
IT - Italia 96
CN - Cina 32
SE - Svezia 32
DE - Germania 26
IE - Irlanda 26
GB - Regno Unito 12
DK - Danimarca 8
HK - Hong Kong 8
AT - Austria 6
SG - Singapore 5
IN - India 4
UA - Ucraina 4
VN - Vietnam 4
CA - Canada 3
FI - Finlandia 3
ID - Indonesia 3
RU - Federazione Russa 3
AU - Australia 1
BG - Bulgaria 1
CH - Svizzera 1
CL - Cile 1
FR - Francia 1
HU - Ungheria 1
RO - Romania 1
TR - Turchia 1
Totale 820
Città #
Ann Arbor 264
Wilmington 50
Fairfield 36
Ashburn 30
Dublin 26
Milan 25
Chandler 21
Frankfurt am Main 21
Cambridge 16
Dearborn 15
Houston 13
Woodbridge 13
New York 10
Seattle 9
Hong Kong 8
Princeton 8
Hangzhou 7
Vienna 5
Altamura 4
Dong Ket 4
Guangzhou 4
Lawrence 4
Singapore 4
Helsinki 3
Jakarta 3
Perugia 3
Shanghai 3
Boardman 2
Cambiago 2
Cusano Milanino 2
Fremont 2
Giugliano in Campania 2
Hebei 2
Jacksonville 2
Los Angeles 2
Nanchang 2
Ottaviano 2
Ottawa 2
Rovato 2
San Mateo 2
San Rocco 2
Seregno 2
Shenyang 2
Taizhou 2
Trieste 2
Verona 2
Andover 1
Beijing 1
Bergamo 1
Bonndorf 1
Boston 1
Budapest 1
Chions 1
Châtillon 1
Edmonton 1
Gatchina 1
Huzhou 1
Jiaxing 1
Kiev 1
Kocaeli 1
Kunming 1
Laurel 1
Legnano 1
Lissone 1
London 1
Magnago 1
Marano di Napoli 1
Mountain View 1
Nanjing 1
Norwalk 1
Pune 1
Riano 1
Rome 1
San Diego 1
Sarego 1
Spello 1
Taiyuan 1
Tianjin 1
Trento 1
Turin 1
Washington 1
Zhengzhou 1
Totale 683
Nome #
Specific Expression of a New Bruton Tyrosine Kinase Isoform (p65BTK) in the Glioblastoma Gemistocytic Histotype 347
Multisite analysis of high-grade serous epithelial ovarian cancers identifies genomic regions of focal and recurrent copy number alteration in 3q26.2 and 8q24.3 284
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial 214
High-dose-rate brachytherapy as monotherapy for localized prostate cancer using three different doses - 14 years of single-centre experience 48
Treatment with gefitinib in elderly patients or patients with poor performance status (PS) affected with non small cell lung carcinoma (NSCLC) [Trattamento con Gefitinib nei pazienti anziani o con scarso performance status (PS), affetti da carcinoma polmonare non a piccole cellule (NSCLC)] 20
Totale 913
Categoria #
all - tutte 2.349
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.349


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201918 0 0 0 0 0 0 0 0 0 0 0 18
2019/2020227 16 12 11 17 18 22 17 33 27 22 30 2
2020/2021310 12 1 35 25 26 37 31 36 36 27 20 24
2021/2022103 16 18 20 8 0 3 1 6 5 7 8 11
2022/2023112 9 34 14 12 3 16 6 6 7 0 5 0
2023/202491 1 2 6 7 10 21 21 8 4 3 0 8
Totale 913